| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7a3886f1cdaa7211491a8f2de9831c4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate |
2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1260479afe29311860998caf38335415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a1444fae3e0c33fb257c42ec2369c4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40740697fef26ce66c26897cac530fa2 |
| publicationDate |
2008-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008038296-A2 |
| titleOfInvention |
Recombinant calcitonin fused to interleukin-2 |
| abstract |
The present invention provides fusion proteins of Calcitonin with Interleukin 2 that have enhanced biological activity compared to Calcitonin. In particular, the present invention provides the process of preparing and using compositions of the fusion protein of Calcitonin with Interleukin 2. Also provided are calcitonin prodrugs and fusion proteins comprising IL2 and calcitonin that are designed to cleave and release calcitonin and/or interleukin-2 on administration and uses thereof. Compositions for treating cancer comprising said fusion proteins are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114591991-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114591991-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021137870-A1 |
| priorityDate |
2006-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |